Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics

International Journal of Psychiatry in Medicine

Volumn 26, Issue 1, 1996, Pages 15-24

  Patten, Scott B ^a   Williams, Jeanne V A ^b   Love, Edgar J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b Calgary General Hospital   (Canada)

Author keywords

benzodiazepines; chemically induced; corticosteroids; depressive symptoms; etiology; sedative hypnotic drugs

Indexed keywords

CORTICOSTEROID; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DRUG INDUCED DISEASE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RATING SCALE; SELF REPORT; SYMPTOMATOLOGY;

EID: 0029912916     PISSN: 00912174     EISSN: None     Source Type: Journal    
DOI: 10.2190/BL97-BWFR-4QR0-CEY7     Document Type: Article

References (26)

1. Hengeveld MW, Ancion AJM, Rooijmans HGM. Prevalence and recognition of depressive disorders in general medical patients. International Journal of Psychiatry in Medicine 1987;17:341-349.
2. Barnes GE, Prosen H. Depression in Canadian general practice attenders. Canadian Journal of Psychiatry 1984;29:2-10.
3. Soffer LJ, Levitt MF, Baehr G. Use of cortisone and adrenocorticotropic hormone in acute disseminated lupus erythematosus. Archives of Internal Medicine 1950;86:558-573.
4. Rome HP, Braceland FJ. The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. The American Journal of Psychiatry 1952; 108:641-651.
5. Grigg JR. Prednisone mood disorder with associated catatonia. Journal of Geriatric Psychiatry and Neurology 1989;2:41-44.
6. Hall RCW, Popkin MK, Stickney SK, Gardner ER. Presentation of the steroid psychosis. Journal of Nervous and Mental Disease 1979;167:229-236.
7. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. Journal of Affective Disorders 1983;5:319-332.
8. Ling MHM, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy. Archives of General Psychiatry 1981;38:471-477.
9. Kershner P, Wang-Chen R. Psychiatric side effects of steroid therapy. Psychosomatics 1989;30:135-139.
10. Gift AG, Wood RM, Cahill CA. Depression, somatization and steroid use in chronic obstructive pulmonary disease. International Journal of Nursing Studies. 1989;26:281-286.
11. Smith BD, Salzman C. Do benzodiazepines cause depression? Hospital and Community Psychiatry 1991;42:1101-1102.
12. Tiller JWG, Schweitzer I. Benzodiazepines, depressants or antidepressants? Drug 1992;44:165-169.
13. Fawcett JA, Kravitz HM. Alprazolam: pharmacokinetics, clinical efficacy, and mechanism of action. Pharmacotherapy 1982;2:243-354.
14. Edwards JG, Inman WHW, Pearce GL, Rawson NSB. Prescription event monitoring of 10895 patients treated with alprazolam. British Journal of Psychiatry 1991;158: 387-392.
15. Lydiard RB, Laraia MT, Ballenger JC, Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. American Journal of Psychiatry 1987;144:664-665.
16. Hall RCW, Joffe JR. Aberrant response to diazepam: a new syndrome. American Journal of Psychiatry 1972;129:738-741.
17. Ryan HF, Merrill B, Scott GE, Krebs R, Thompson BL. Increase in suicidal thoughts and tendencies. Association with diazepam therapy. Journal of the American Medical Association 1968;203:135-137.
18. Hall RCW, Zisook S. Paradoxical reactions to benzodiazepines. British Journal of Clinical Pharmacology 1981;11:99S-104S.
19. Buckner JC, Mandell W. Risk factors for depressive symptomatology in a drug using population. American Journal of Public Health 1988;260:3441-3445.
20. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
21. Rahe RH. The pathway between subjects' recent life changes and their near-future illness reports: representative results and methodological issues. In: Dohrenwend BS, Dohrenwend BP, editors. Stressful life events: their nature and effects. New York: John Wiley & Sons, 1974:73-86.
22. Rahe RH. Epidemiological studies of life change and illness. International Journal of Psychiatry in Medicine 1975;6:133-146.
23. Belloc NB, Breslow L, Hochstim JR. Measurement of physical health in a general population. American Journal of Epidemiology 1971;93:328-336.
24. Kaplan GA, Roberts RE, Camacho TC, Coyne JC. Psychosocial predictors of depression. Prospective evidence from the Human Population Laboratory studies. American Journal of Epidemiology 1987;125:206-220.
25. Dubrovsky B. Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression. Journal of Psychiatry and Neuroscience 1993;18:4-16.
26. Dinan TG. Glucocorticoids and the genesis of depressive illness. A psychobiological model. British Journal of Psychiatry 1994;164:365-371.